JOB DESCRIPTION
Research Group Leader - Epigenetics and Chronic Obstructive Pulmonary Disease
What we offer:
A research group leader position is offered for an initial term of two years, with the possibility of prolongation for up to two additional years, and an option for a permanent position.
As part of the research group in the above mentioned field the posts include a generous funding package covering personal salary, consumables, services, travels, as well as access to the core facilities of neighboring research institutions and biotechnology companies in Heidelberg.
There is flexibility over starting dates, but successful applicants are welcome to take up post starting June 15, 2015.
To submit your application for this position, please click on the "Apply through website" button.
Only applications received before February 15, 2015 will be considered. As part of the online application procedure candidates will be required to enter detailed information about their previous work and submit a competitive project proposal.
After a first selection round, candidates will be invited to a five-day innovation boot camp in Heidelberg. The invitation includes full coverage of travel expenses, accommodation, sightseeing, and food for the entire workshop which will take place from April 24 to 28, 2015. With guidance of experienced mentors, candidates will jointly work on their project proposals and present them in front of a jury on the final day. Successful candidates will be offered a position at the BioMed X Innovation Center.
DESIRED SKILLS AND EXPERIENCE
Applications are welcome from early career scientists with an outstanding track record in the field of:
Epigenetics and Chronic Obstructive Pulmonary Disease (COPD)
Boehringer Ingelheim is interested in identifying new therapeutic concepts for the treatment of COPD patients. As part of the application process, research project proposals are requested that prove the therapeutic utility of defined epigenetic readers, writers and erasers or targeting non-coding RNAs in the following areas:
- Prevent tissue destruction and emphysema development;
- Reverse subepithelial and smooth muscle remodeling;
- Repair and regenerate the airway epithelial barrier;
- Control and resolve inflammation;
- Reverse small airway fibrosis.
Successful proposals will demonstrate the relevance of the molecular targets in test systems derived from COPD patients. Original, unprecedented ideas and unique experimental approaches are particularly encouraged.
The position is intended to suit candidates with typically between four and eight years of postdoctoral experience who would, once established, be in a strong position to enter a leadership career path either in academia or industry.
ABOUT THE EMPLOYER
The BioMed X Innovation Center constitutes a novel way of collaboration at the interface between academia and industry. At this center, distinguished early career scientists recruited from all over the world are working jointly on novel pre-clinical research projects in the fields of biomedicine, molecular biology, cell biology and bioinformatics.
These interdisciplinary project teams are conducting groundbreaking biomedical research in an open innovation lab facility on the campus of the University of Heidelberg, under the guidance of experienced mentors from academia and industry while expanding their scientific network and receiving an intensive entrepreneurship and leadership training.
Each BioMed X project team is sponsored by an industry partner. The sponsor of this call for application is Boehringer Ingelheim.